A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine: comparing the real-world registry data vs. randomized controlled trial

References

• GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392:1923–7. doi:10.1016/S0140-6736(18)32225-6.
   PubMed Web of Science ®Google Scholar
• Irazola VE, Gutierrez L, Bloomfield G, Carrillo-Larco RM, Dorairaj P, Gaziano T, Levitt NS, Miranda JJ, Ortiz AB, Steyn K, et al. Hypertension prevalence, awareness, treatment, and control in selected lmic communities: results from the nhlbi/uhg network of centers of excellence for chronic diseases. Glob Heart. 2016;11(1):47–59. doi:10.1016/j.gheart.2015.12.008.
   PubMed Web of Science ®Google Scholar
• Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, Bahonar A, Chifamba J, Dagenais G, Diaz R, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–68. doi:10.1001/jama.2013.184182.
   PubMed Web of Science ®Google Scholar
• Laurent S. Antihypertensive drugs. Pharmacol Res. 2017;124:116–25. doi:10.1016/j.phrs.2017.07.026.
   PubMed Web of Science ®Google Scholar
• Tedla YG, Bautista LE. Drug side effect symptoms and adherence to antihypertensive medication. Am J Hypertens. 2016;29(6):772–79. doi:10.1093/ajh/hpv185.
   PubMed Web of Science ®Google Scholar
• Mohammed S, Hanxing L, Fang L, Algradi AM, Alradhi M, Safi M, Shumin L. Integrated chinese herbal medicine with western medicine versus western medicine in the effectiveness of primary hypertension treatment: a systematic review and meta-analysis of randomized controlled trials. J Ethnopharmacol. 2023;300:115703. doi:10.1016/j.jep.2022.115703.
   PubMed Web of Science ®Google Scholar
• Li J. Traditional chinese medicine in treating hypertension. Circ Cardiovasc Qual Outcomes. 2022;15(3):e8723. doi:10.1161/CIRCOUTCOMES.121.008723.
   Web of Science ®Google Scholar
• Xinke Z, Yingdong L, Mingxia F, Kai L, Kaibing C, Yuqing L, Shaobo S, Peng S, Bin L. Chinese herbal medicine for the treatment of primary hypertension: a methodology overview of systematic reviews. Syst Rev. 2016;5(1):180. doi:10.1186/s13643-016-0353-y.
   PubMedGoogle Scholar
• Xiong X, Yang X, Liu Y, Zhang Y, Wang P, Wang J. Chinese herbal formulas for treating hypertension in traditional chinese medicine: perspective of modern science. Hypertens Res. 2013;36(7):570–79. doi:10.1038/hr.2013.18.
   PubMed Web of Science ®Google Scholar
• Meng T, Wang P, Xie X, Li T, Kong L, Xu Y, Cao K, Gao Y, He Q, Lai X. Efficacy and safety of songling xuemaikang capsule for essential hypertension: a systematic review and meta-analysis of randomized controlled trials. Phytomed. 2022;107:154459. doi:10.1016/j.phymed.2022.154459.
   PubMed Web of Science ®Google Scholar
• Hong YD, Jansen JP, Guerino J, Berger ML, Crown W, Goettsch WG, Mullins CD, Willke RJ, Orsini LS. Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials. BMC Med. 2021;19(1):307. doi:10.1186/s12916-021-02176-1.
   PubMed Web of Science ®Google Scholar
• Thompson D. Replication of randomized, controlled trials using real-world data: what could go wrong? Value Health. 2021;24(1):112–15. doi:10.1016/j.jval.2020.09.015.
   PubMed Web of Science ®Google Scholar
• Collins R, Bowman L, Landray M, Peto R. The magic of randomization versus the myth of real-world evidence. N Engl J Med. 2020;382(7):674–78. doi:10.1056/NEJMsb1901642.
   PubMed Web of Science ®Google Scholar
• Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, Craig TJ, Nordentoft M, Srihari VH, Guloksuz S, et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression. JAMA Psych. 2018;75(6):555–65. doi:10.1001/jamapsychiatry.2018.0623.
   PubMed Web of Science ®Google Scholar
• Jansen I, Mulder M, Goldhoorn RB. Endovascular treatment for acute ischaemic stroke in routine clinical practice: prospective, observational cohort study (MR CLEAN registry). BMJ. 2018;360:k949. doi:10.1136/bmj.k949.
   PubMedGoogle Scholar
• Munk NE, Knudsen JS, Pottegard A, Witte DR, Thomsen RW. Differences between randomized clinical trial participants and real-world empagliflozin users and the changes in their glycated hemoglobin levels. JAMA Netw Open. 2020;3(2):e1920949. doi:10.1001/jamanetworkopen.2019.20949.
   PubMed Web of Science ®Google Scholar
• Rivera-Caravaca JM, Esteve-Pastor MA, Marin F, Valdes M, Vicente V, Roldan V, Lip G. A propensity score matched comparison of clinical outcomes in atrial fibrillation patients taking vitamin k antagonists: comparing the “real-world” vs clinical trials. Mayo Clin Proc. 2018;93(8):1065–73. doi:10.1016/j.mayocp.2018.01.028.
   PubMed Web of Science ®Google Scholar
• Khozin S, Blumenthal GM, Pazdur R. Real-world data for clinical evidence generation in oncology. J Natl Cancer Inst. 2017;109(11). doi:10.1093/jnci/djx187.
   PubMedGoogle Scholar
• Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, Lavange L, Marinac-Dabic D, Marks PW, Robb MA, et al. Real-world evidence — What is it and What can it tell us? N Engl J Med. 2016;375(23):2293–97. doi:10.1056/NEJMsb1609216.
   PubMed Web of Science ®Google Scholar
• Berger ML, Lipset C, Gutteridge A, Axelsen K, Subedi P, Madigan D. Optimizing the leveraging of real-world data to improve the development and use of medicines. Value Health. 2015;18(1):127–30. doi:10.1016/j.jval.2014.10.009.
   PubMed Web of Science ®Google Scholar
• Liu LS. 2010 Chinese guidelines for the management of hypertension. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(7):579–615.
   PubMedGoogle Scholar
• Lai X, Dong Z, Wu S, Zhou X, Zhang G, Xiong S, Wu W, Cao R, Wang X, Hua Q, et al. Efficacy and safety of chinese herbal medicine compared with losartan for mild essential hypertension: a randomized, multicenter, double-blind, noninferiority trial. Circ Cardiovasc Qual Outcomes. 2022;15(3):e7923. doi:10.1161/CIRCOUTCOMES.121.007923.
   Web of Science ®Google Scholar
• Little RJ, D’Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367(14):1355–60. doi:10.1056/NEJMsr1203730.
   PubMed Web of Science ®Google Scholar
• Concato J, Corrigan-Curay J. Real-world evidence — Where are We now? N Engl J Med. 2022;386(18):1680–82. doi:10.1056/NEJMp2200089.
   PubMed Web of Science ®Google Scholar
• Wang SV, Schneeweiss S, Gagne JJ, Evers T, Gerlinger C, Desai R, Najafzadeh M. Using real-world data to extrapolate evidence from randomized controlled trials. Clin Pharmacol Ther. 2019;105(5):1156–63. doi:10.1002/cpt.1210.
   PubMed Web of Science ®Google Scholar
• Potpara TS. Dabigatran in ‘real-world’ clinical practice for stroke prevention in patients with non-valvular atrial fibrillation. Thromb Haemost. 2015;114(12):1093–98. doi:10.1160/TH15-10-0825.
   PubMedGoogle Scholar
• Hylek EM, Ko D, Cove CL. Gaps in translation from trials to practice: non-vitamin k antagonist oral anticoagulants (noacs) for stroke prevention in atrial fibrillation. Thromb Haemost. 2014;111(5):783–88. doi:10.1160/TH13-12-1032.
   PubMed Web of Science ®Google Scholar
• Callahan A, Shah NH, Chen JH. Research and reporting considerations for observational studies using electronic health record data. Ann Intern Med. 2020;172:S79–S84. doi:10.7326/M19-087311_Supplement.
   PubMed Web of Science ®Google Scholar
• Bothwell LE, Podolsky SH. The emergence of the randomized, controlled trial. N Engl J Med. 2016;375(6):501–04. doi:10.1056/NEJMp1604635.
   PubMed Web of Science ®Google Scholar
• Eaglstein WH. Real-world evidence–What is it and does it matter for approval of drugs? J Am Acad Dermatol. 2018;79(2):390–91. doi:10.1016/j.jaad.2018.01.040.
   PubMed Web of Science ®Google Scholar